Banks - Diversified
Compare Stocks
4 / 10Stock Comparison
UBS vs C vs JPM vs MS
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Diversified
Banks - Diversified
Financial - Capital Markets
UBS vs C vs JPM vs MS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Banks - Diversified | Banks - Diversified | Banks - Diversified | Financial - Capital Markets |
| Market Cap | $137.82B | $225.59B | $825.89B | $302.59B |
| Revenue (TTM) | $59.05B | $170.71B | $270.79B | $103.14B |
| Net Income (TTM) | $6.27B | $14.69B | $58.03B | $16.18B |
| Gross Margin | 63.6% | 41.7% | 58.6% | 55.6% |
| Operating Margin | 11.9% | 10.0% | 27.7% | 17.1% |
| Forward P/E | 13.8x | 11.6x | 13.6x | 16.2x |
| Total Debt | $356.12B | $590.56B | $751.15B | $360.49B |
| Cash & Equiv. | $209.86B | $276.53B | $469.32B | $75.74B |
UBS vs C vs JPM vs MS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| UBS Group AG (UBS) | 100 | 422.7 | +322.7% |
| Citigroup Inc. (C) | 100 | 262.1 | +162.1% |
| JPMorgan Chase & Co. (JPM) | 100 | 310.5 | +210.5% |
| Morgan Stanley (MS) | 100 | 436.7 | +336.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: UBS vs C vs JPM vs MS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
UBS lags the leaders in this set but could rank higher in a more targeted comparison.
C carries the broadest edge in this set and is the clearest fit for value and dividends.
- Lower P/E (11.6x vs 16.2x)
- 2.1% yield, 3-year raise streak, vs JPM's 1.7%
- +87.2% vs JPM's +25.2%
JPM is the #2 pick in this set and the best alternative if income & stability and sleep-well-at-night is your priority.
- Dividend streak 14 yrs, beta 1.00, yield 1.7%
- Lower volatility, beta 1.00, current ratio 0.65x
- PEG 1.04 vs UBS's 12.52
- Beta 1.00, yield 1.7%, current ratio 0.65x
MS is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 16.8%, EPS growth 53.5%
- 7.3% 10Y total return vs JPM's 461.3%
- 16.8% NII/revenue growth vs UBS's -20.4%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.8% NII/revenue growth vs UBS's -20.4% | |
| Value | Lower P/E (11.6x vs 16.2x) | |
| Quality / Margins | Efficiency ratio 0.3% vs UBS's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 1.00 vs C's 1.51, lower leverage | |
| Dividends | 2.1% yield, 3-year raise streak, vs JPM's 1.7% | |
| Momentum (1Y) | +87.2% vs JPM's +25.2% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs UBS's 0.5% |
UBS vs C vs JPM vs MS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
UBS vs C vs JPM vs MS — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 1 of 6 categories
C leads 1 • UBS leads 0 • MS leads 0 • 4 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — JPM and MS each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $270.8B annually — 4.6x UBS's $59.1B. JPM is the more profitable business, keeping 21.6% of every revenue dollar as net income compared to C's 7.4%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $59.1B | $170.7B | $270.8B | $103.1B |
| EBITDAEarnings before interest/tax | $9.9B | $24.1B | $81.3B | $26.3B |
| Net IncomeAfter-tax profit | $6.3B | $14.7B | $58.0B | $16.2B |
| Free Cash FlowCash after capex | $3.9B | -$76.0B | -$119.7B | -$6.7B |
| Gross MarginGross profit ÷ Revenue | +63.6% | +41.7% | +58.6% | +55.6% |
| Operating MarginEBIT ÷ Revenue | +11.9% | +10.0% | +27.7% | +17.1% |
| Net MarginNet income ÷ Revenue | +10.4% | +7.4% | +21.6% | +13.0% |
| FCF MarginFCF ÷ Revenue | -26.4% | -15.3% | -15.5% | -2.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +26.1% | +23.2% | +16.0% | +48.9% |
Valuation Metrics
Evenly matched — C and JPM each lead in 3 of 6 comparable metrics.
Valuation Metrics
At 15.5x trailing earnings, JPM trades at a 35% valuation discount to MS's 23.9x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 1.19x vs UBS's 21.49x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $137.8B | $225.6B | $825.9B | $302.6B |
| Enterprise ValueMkt cap + debt − cash | $284.1B | $539.6B | $1.11T | $587.3B |
| Trailing P/EPrice ÷ TTM EPS | 23.75x | 21.70x | 15.51x | 23.92x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.84x | 11.61x | 13.56x | 16.24x |
| PEG RatioP/E ÷ EPS growth rate | 21.49x | — | 1.19x | 2.69x |
| EV / EBITDAEnterprise value multiple | 29.75x | 25.27x | 13.34x | 25.81x |
| Price / SalesMarket cap ÷ Revenue | 2.33x | 1.32x | 3.05x | 2.93x |
| Price / BookPrice ÷ Book value/share | 1.62x | 1.17x | 2.56x | 2.91x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — |
Profitability & Efficiency
JPM leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 16.1% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $7 for C. JPM carries lower financial leverage with a 2.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to UBS's 3.94x. On the Piotroski fundamental quality scale (0–9), UBS scores 6/9 vs MS's 5/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +7.0% | +6.9% | +16.1% | +14.6% |
| ROA (TTM)Return on assets | +0.4% | +0.6% | +1.3% | +1.2% |
| ROICReturn on invested capital | +1.2% | +1.6% | +5.4% | +2.9% |
| ROCEReturn on capital employed | +1.1% | +3.0% | +8.2% | +3.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 5 | 5 |
| Debt / EquityFinancial leverage | 3.94x | 2.82x | 2.18x | 3.42x |
| Net DebtTotal debt minus cash | $146.3B | $314.0B | $281.8B | $284.7B |
| Cash & Equiv.Liquid assets | $209.9B | $276.5B | $469.3B | $75.7B |
| Total DebtShort + long-term debt | $356.1B | $590.6B | $751.1B | $360.5B |
| Interest CoverageEBIT ÷ Interest expense | 0.33x | 0.24x | 0.74x | 0.44x |
Total Returns (Dividends Reinvested)
C leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UBS five years ago would be worth $30,472 today (with dividends reinvested), compared to $18,638 for C. Over the past 12 months, C leads with a +87.2% total return vs JPM's +25.2%. The 3-year compound annual growth rate (CAGR) favors C at 43.1% vs JPM's 32.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -3.4% | +9.8% | -5.0% | +5.7% |
| 1-Year ReturnPast 12 months | +47.4% | +87.2% | +25.2% | +63.0% |
| 3-Year ReturnCumulative with dividends | +139.5% | +193.0% | +134.6% | +138.4% |
| 5-Year ReturnCumulative with dividends | +204.7% | +86.4% | +104.3% | +136.2% |
| 10-Year ReturnCumulative with dividends | +232.0% | +236.6% | +461.3% | +732.3% |
| CAGR (3Y)Annualised 3-year return | +33.8% | +43.1% | +32.9% | +33.6% |
Risk & Volatility
Evenly matched — JPM and MS each lead in 1 of 2 comparable metrics.
Risk & Volatility
JPM is the less volatile stock with a 1.00 beta — it tends to amplify market swings less than C's 1.51 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MS currently trades 97.6% from its 52-week high vs UBS's 90.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.20x | 1.46x | 1.00x | 1.36x |
| 52-Week HighHighest price in past year | $49.36 | $135.29 | $337.25 | $194.83 |
| 52-Week LowLowest price in past year | $30.36 | $69.65 | $248.83 | $118.20 |
| % of 52W HighCurrent price vs 52-week peak | +90.0% | +95.4% | +90.8% | +97.6% |
| RSI (14)Momentum oscillator 0–100 | 68.0 | 56.9 | 59.4 | 66.0 |
| Avg Volume (50D)Average daily shares traded | 2.7M | 11.5M | 8.3M | 5.4M |
Analyst Outlook
Evenly matched — C and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: UBS as "Buy", C as "Buy", JPM as "Buy", MS as "Buy". Consensus price targets imply 10.6% upside for JPM (target: $339) vs -46.9% for UBS (target: $24). For income investors, C offers the higher dividend yield at 2.12% vs UBS's 1.62%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $23.57 | $140.50 | $338.78 | $203.00 |
| # AnalystsCovering analysts | 29 | 27 | 61 | 52 |
| Dividend YieldAnnual dividend ÷ price | +1.6% | +2.1% | +1.7% | +2.0% |
| Dividend StreakConsecutive years of raises | 4 | 3 | 14 | 11 |
| Dividend / ShareAnnual DPS | $0.72 | $2.73 | $5.13 | $3.81 |
| Buyback YieldShare repurchases ÷ mkt cap | +3.1% | +3.3% | +3.5% | +1.4% |
JPM leads in 1 of 6 categories (Profitability & Efficiency). C leads in 1 (Total Returns). 4 tied.
UBS vs C vs JPM vs MS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is UBS or C or JPM or MS a better buy right now?
For growth investors, Morgan Stanley (MS) is the stronger pick with 16.
8% revenue growth year-over-year, versus -20. 4% for UBS Group AG (UBS). JPMorgan Chase & Co. (JPM) offers the better valuation at 15. 5x trailing P/E (13. 6x forward), making it the more compelling value choice. Analysts rate UBS Group AG (UBS) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — UBS or C or JPM or MS?
On trailing P/E, JPMorgan Chase & Co.
(JPM) is the cheapest at 15. 5x versus Morgan Stanley at 23. 9x. On forward P/E, Citigroup Inc. is actually cheaper at 11. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 1. 04x versus UBS Group AG's 12. 52x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — UBS or C or JPM or MS?
Over the past 5 years, UBS Group AG (UBS) delivered a total return of +204.
7%, compared to +86. 4% for Citigroup Inc. (C). Over 10 years, the gap is even starker: MS returned +743. 3% versus C's +228. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — UBS or C or JPM or MS?
By beta (market sensitivity over 5 years), JPMorgan Chase & Co.
(JPM) is the lower-risk stock at 1. 00β versus Citigroup Inc. 's 1. 46β — meaning C is approximately 46% more volatile than JPM relative to the S&P 500. On balance sheet safety, JPMorgan Chase & Co. (JPM) carries a lower debt/equity ratio of 2% versus 4% for UBS Group AG — giving it more financial flexibility in a downturn.
05Which is growing faster — UBS or C or JPM or MS?
By revenue growth (latest reported year), Morgan Stanley (MS) is pulling ahead at 16.
8% versus -20. 4% for UBS Group AG (UBS). On earnings-per-share growth, the picture is similar: Morgan Stanley grew EPS 53. 5% year-over-year, compared to 21. 7% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — UBS or C or JPM or MS?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 21. 6% net margin versus 7. 4% for Citigroup Inc. — meaning it keeps 21. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 27. 7% versus 10. 0% for C. At the gross margin level — before operating expenses — UBS leads at 63. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is UBS or C or JPM or MS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 1. 04x versus UBS Group AG's 12. 52x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Citigroup Inc. (C) trades at 11. 6x forward P/E versus 16. 2x for Morgan Stanley — 4. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 10. 6% to $338. 78.
08Which pays a better dividend — UBS or C or JPM or MS?
All stocks in this comparison pay dividends.
Citigroup Inc. (C) offers the highest yield at 2. 1%, versus 1. 6% for UBS Group AG (UBS).
09Is UBS or C or JPM or MS better for a retirement portfolio?
For long-horizon retirement investors, JPMorgan Chase & Co.
(JPM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 00), 1. 7% yield, +454. 6% 10Y return). Both have compounded well over 10 years (JPM: +454. 6%, C: +228. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between UBS and C and JPM and MS?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: UBS is a mid-cap quality compounder stock; C is a large-cap quality compounder stock; JPM is a large-cap deep-value stock; MS is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.